Business Description
Sansure Biotech Inc
ISIN : CNE1000043J1
Share Class Description:
SHSE:688289: Class ACompare
Compare
Traded in other countries / regions
688289.China IPO Date
2020-08-28Description
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 235.89 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | 0.03 | |||||
| Interest Coverage | 314.32 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.71 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 152.1 | |||||
| 3-Year EBITDA Growth Rate | 220.5 | |||||
| 3-Year EPS without NRI Growth Rate | 242.4 | |||||
| 3-Year Book Growth Rate | 130.1 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.32 | |||||
| 9-Day RSI | 36.32 | |||||
| 14-Day RSI | 38.26 | |||||
| 6-1 Month Momentum % | 37.74 | |||||
| 12-1 Month Momentum % | -9.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.89 | |||||
| Quick Ratio | 7.45 | |||||
| Cash Ratio | 6.24 | |||||
| Days Inventory | 117.7 | |||||
| Days Sales Outstanding | 118.94 | |||||
| Days Payable | 158.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.83 | |||||
| Dividend Payout Ratio | 0.98 | |||||
| Forward Dividend Yield % | 5.75 | |||||
| 5-Year Yield-on-Cost % | 3.83 | |||||
| 3-Year Average Share Buyback Ratio | -3.4 | |||||
| Shareholder Yield % | 3.76 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.21 | |||||
| Operating Margin % | 24.4 | |||||
| Net Margin % | 21.17 | |||||
| FCF Margin % | 20.47 | |||||
| ROE % | 8.52 | |||||
| ROA % | 7.41 | |||||
| ROIC % | 24.33 | |||||
| ROC (Joel Greenblatt) % | 61.67 | |||||
| ROCE % | 10.54 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.04 | |||||
| PE Ratio without NRI | 13.91 | |||||
| Price-to-Owner-Earnings | 27.71 | |||||
| PS Ratio | 3.6 | |||||
| PB Ratio | 1.46 | |||||
| Price-to-Tangible-Book | 1.48 | |||||
| Price-to-Free-Cash-Flow | 17.59 | |||||
| Price-to-Operating-Cash-Flow | 9.32 | |||||
| EV-to-EBIT | 7.44 | |||||
| EV-to-EBITDA | 7.44 | |||||
| EV-to-Revenue | 1.97 | |||||
| EV-to-FCF | 9.63 | |||||
| Price-to-Graham-Number | 0.96 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Price-to-Net-Cash | 2.75 | |||||
| Earnings Yield (Greenblatt) % | 13.44 | |||||
| FCF Yield % | 5.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sansure Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,014.667 | ||
| EPS (TTM) (Â¥) | 1.08 | ||
| Beta | 0.8 | ||
| Volatility % | 38.99 | ||
| 14-Day RSI | 38.26 | ||
| 14-Day ATR (Â¥) | 0.64477 | ||
| 20-Day SMA (Â¥) | 19.2005 | ||
| 12-1 Month Momentum % | -9.1 | ||
| 52-Week Range (Â¥) | 14.72 - 23.78 | ||
| Shares Outstanding (Mil) | 588.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sansure Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sansure Biotech Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sansure Biotech Inc Frequently Asked Questions
What is Sansure Biotech Inc(SHSE:688289)'s stock price today?
The current price of SHSE:688289 is ¥18.33. The 52 week high of SHSE:688289 is ¥23.78 and 52 week low is ¥14.72.
When is next earnings date of Sansure Biotech Inc(SHSE:688289)?
The next earnings date of Sansure Biotech Inc(SHSE:688289) is .
Does Sansure Biotech Inc(SHSE:688289) pay dividends? If so, how much?
The Dividend Yield %  of Sansure Biotech Inc(SHSE:688289) is 3.83% (As of Today), Highest Dividend Payout Ratio of Sansure Biotech Inc(SHSE:688289) was 0.98. The lowest was 0.11. And the median was 0.21. The  Forward Dividend Yield % of Sansure Biotech Inc(SHSE:688289) is 5.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers